USAID's Maternal and Child Survival Program/Jhpiego, Washington, DC, USA.
Faculty of Health Sciences, University of Stavanger, Stavanger, Norway.
Int J Gynaecol Obstet. 2020 Feb;148(2):145-156. doi: 10.1002/ijgo.13014. Epub 2019 Dec 5.
Using Doppler to improve detection of intrapartum fetal heart rate (FHR) abnormalities coupled with appropriate, timely intrapartum care in low- and middle-income countries (LMIC) can save lives.
To review studies using Doppler to improve detection of intrapartum FHR abnormalities and intrapartum care quality in LMIC health facilities.
PubMed, Web of Science, Embase, Global Health, and Scopus were searched from inception to October 2018 by combining terms for Doppler, perinatal outcomes, and FHR monitoring.
Selected studies compared Doppler and Pinard stethoscope for detecting/monitoring intrapartum FHR, or described provider and maternal preferences for FHR monitoring in LMIC settings.
Two team members independently screened and collected data. Risk of bias was assessed by Cochrane EPOC criteria.
Eleven studies from eight countries were included. Doppler was superior at detecting abnormal intrapartum FHR as compared with Pinard stethoscope, but was not associated with improved perinatal outcomes. Using Doppler on admission helped to accurately measure perinatal deaths occurring after facility admission.
Studies and program learning are needed to translate improved detection of FHR abnormalities to improved case management in LMICs. Doppler should be used to calculate a facility indicator of intrapartum care quality. PROSPERO registration: CRD42019121924.
在中低收入国家(LMIC),使用多普勒技术提高胎儿心率(FHR)异常的检出率,并辅以适当的、及时的分娩期护理,可以拯救生命。
综述使用多普勒技术提高中低收入国家卫生机构分娩期 FHR 异常检出率和分娩期护理质量的研究。
通过组合多普勒、围产结局和 FHR 监测的术语,从建库至 2018 年 10 月,在 PubMed、Web of Science、Embase、Global Health 和 Scopus 上进行检索。
入选研究比较了多普勒和 Pinard 听诊器用于检测/监测分娩期 FHR,或描述了提供者和产妇在中低收入国家环境下对 FHR 监测的偏好。
两名团队成员独立筛选和收集数据。采用 Cochrane EPOC 标准评估偏倚风险。
纳入了来自 8 个国家的 11 项研究。与 Pinard 听诊器相比,多普勒在检测异常的分娩期 FHR 方面更具优势,但与改善围产结局无关。入院时使用多普勒有助于准确测量入院后发生的围产死亡。
需要进行研究和方案学习,以将 FHR 异常的检出率提高转化为中低收入国家的病例管理改善。多普勒应被用于计算分娩期护理质量的机构指标。PROSPERO 注册号:CRD42019121924。